We are live on ! Find out more
PSC

Patient Square Capital Portfolio holdings

AUM $564M
1-Year Est. Return 261.3%
This Fund
S&P 500
This Quarter Est. Return
+24.72%
1 Year Est. Return
+261.3%
3 Year Est. Return
+328.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$81M
Cap. Flow
+$52M
Cap. Flow %
25.32%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$52M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$24.1B
$127M 62.03%
12,639,920
+5,813,953
+85% +$52M
EAR
2
DELISTED
Eargo, Inc. Common Stock
EAR
$78M 37.97%
15,821,299
– –

Similar funds

TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $565M AUM

Patient Square Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Patient Square Capital held 2 positions worth $205M, up 65% from $124M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Patient Square Capital deployed $52M of net new capital in Q2 2023, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Patient Square Capital added most to Roivant Sciences in Q2 2023, an estimated $52M increase.
  • Patient Square Capital's ten largest holdings make up 100% of its $205M portfolio in Q2 2023.
  • Patient Square Capital opened 0 new positions and closed 0 in Q2 2023.
  • Patient Square Capital's portfolio value rose 65% quarter-over-quarter to $205M.

Based on Patient Square Capital's 13F filing for Q2 2023, filed 11 Aug 2023.